Blaze Bioscience, Inc. is a privately held biotechnology company dedicated to improving the lives of cancer patients, starting with kids undergoing brain cancer surgery. By leveraging our Tumor Paint technology®, including the CANVAS Imaging system® and our CDP Discovery Platform, our goal is to make the detection, removal, and treatment of all cancers sensitive, reliable, and accessible, especially early-stage cancers where cure may still be possible.
View Top Employees from Blaze BioscienceWebsite | http://www.blazebioscience.com/ |
Revenue | $13.6 million |
Employees | 35 (35 on RocketReach) |
Founded | 2010 |
Address | 530 Fairview Ave N, Seattle, Washington, US |
Phone | (206) 535-8144 |
Fax | (206) 257-5924 |
Technologies |
JavaScript,
HTML,
Twitter
+12 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Other Healthcare Technology Systems, Health Care, Medical |
Web Rank | 9 Million |
Keywords | Jim Olson Blaze, Blaze Bioscience, Blaze Bioscience Stock |
Competitors | Cellectar Biosciences, Inc., DelMar Pharmaceuticals, OncoSec, Targepeutics, UbiVac |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies |
Looking for a particular Blaze Bioscience employee's phone or email?
The Blaze Bioscience annual revenue was $13.6 million in 2024.
Claudia Jochheim is the Executive Vice President, Research and Development of Blaze Bioscience.
35 people are employed at Blaze Bioscience.
Blaze Bioscience is based in Seattle, Washington.
The NAICS codes for Blaze Bioscience are [5417, 541, 54, 541714, 54171].
The SIC codes for Blaze Bioscience are [87, 873].